Sources

12 Total Sources

Definium Shares Jump After 2nd Phase 3 LSD Anxiety Study Beats 4-Point Bar

Center75%

Far Right25%

Investor's Business Daily8d ago

Definium Therapeutics Stock Jumps After Second Positive Phase 3 LSD Drug Study for Anxiety

allsci.com9d ago

Definium's LSD formulation scores second Phase III win in GAD

pharmaphorum9d ago

Definium chalks up new phase 3 win for LSD-based therapy | pharmaphorum

Yahoo Finance9d ago

Definium Therapeutics' DT120 Psychedelic Drug Delivers Positive Late-Stage GAD Trial Results

Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder : r/DTIC

Yahoo Finance1m ago

Definium Therapeutics, Inc. (DFTX) Stock Price, News, Quote & History - Yahoo Finance

Definium says LSD-based pill reduces anxiety in late-stage study | Reuters

StockTitan9d ago

Definium posts strong Phase 3 GAD trial results | DFTX 8-K Filing

MD Magazine9d ago

DT120 ODT Meets Primary Endpoint in Voyage Phase 3 GAD Trial | HCPLive

Psychiatric Times9d ago

DT120 (Lysergide) Shows Rapid, Lasting Relief for Generalized Anxiety in Phase 3 Trial | Psychiatric Times

Definium's LSD asset beats analyst expectations in Phase 3 anxiety readout - BioSpace

Congratulations to the Definium Therapeutics team today for another positive result. The Voyage readout today marks the second positive Phase 3 result for an LSD-based therapy in eight weeks. In GAD,… |